134 related articles for article (PubMed ID: 21476495)
1. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
[TBL] [Abstract][Full Text] [Related]
2. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
3. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
[TBL] [Abstract][Full Text] [Related]
4. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
[TBL] [Abstract][Full Text] [Related]
5. Beta-homo-amino acid scan of angiotensin IV.
Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D
J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881
[TBL] [Abstract][Full Text] [Related]
6. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
[TBL] [Abstract][Full Text] [Related]
7. Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor.
Axén A; Andersson H; Lindeberg G; Rönnholm H; Kortesmaa J; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
J Pept Sci; 2007 Jul; 13(7):434-44. PubMed ID: 17559064
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
[TBL] [Abstract][Full Text] [Related]
9. Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat.
Stragier B; Demaegdt H; De Bundel D; Smolders I; Sarre S; Vauquelin G; Ebinger G; Michotte Y; Vanderheyden P
Brain Res; 2007 Feb; 1131(1):97-105. PubMed ID: 17169335
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).
Demaegdt H; De Backer JP; Lukaszuk A; Tóth G; Szemenyei E; Tourwé D; Vauquelin G
Fundam Clin Pharmacol; 2012 Apr; 26(2):194-7. PubMed ID: 21477268
[TBL] [Abstract][Full Text] [Related]
11. Regulation of insulin-regulated membrane aminopeptidase activity by its C-terminal domain.
Ascher DB; Cromer BA; Morton CJ; Volitakis I; Cherny RA; Albiston AL; Chai SY; Parker MW
Biochemistry; 2011 Apr; 50(13):2611-22. PubMed ID: 21348480
[TBL] [Abstract][Full Text] [Related]
12. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.
Nikolaou A; Van den Eynde I; Tourwé D; Vauquelin G; Tóth G; Mallareddy JR; Poglitsch M; Van Ginderachter JA; Vanderheyden PM
Eur J Pharmacol; 2013 Feb; 702(1-3):93-102. PubMed ID: 23376157
[TBL] [Abstract][Full Text] [Related]
13. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
[TBL] [Abstract][Full Text] [Related]
14. Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.
Demaegdt H; Gard P; De Backer JP; Lukaszuk A; Szemenyei E; Tóth G; Tourwé D; Vauquelin G
Mol Cell Endocrinol; 2011 Jun; 339(1-2):34-44. PubMed ID: 21457753
[TBL] [Abstract][Full Text] [Related]
15. Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.
Lukaszuk A; Demaegdt H; Van den Eynde I; Vanderheyden P; Vauquelin G; Tourwé D
J Pept Sci; 2011 Aug; 17(8):545-53. PubMed ID: 21538707
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.
Demaegdt H; Vanderheyden P; De Backer JP; Mosselmans S; Laeremans H; Le MT; Kersemans V; Michotte Y; Vauquelin G
Biochem Pharmacol; 2004 Sep; 68(5):885-92. PubMed ID: 15294451
[TBL] [Abstract][Full Text] [Related]
18. Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density.
Diwakarla S; Nylander E; Grönbladh A; Vanga SR; Khan YS; Gutiérrez-de-Terán H; Ng L; Pham V; Sävmarker J; Lundbäck T; Jenmalm-Jensen A; Andersson H; Engen K; Rosenström U; Larhed M; Åqvist J; Chai SY; Hallberg M
Mol Pharmacol; 2016 Apr; 89(4):413-24. PubMed ID: 26769413
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase.
Albiston AL; Morton CJ; Ng HL; Pham V; Yeatman HR; Ye S; Fernando RN; De Bundel D; Ascher DB; Mendelsohn FA; Parker MW; Chai SY
FASEB J; 2008 Dec; 22(12):4209-17. PubMed ID: 18716029
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
